<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01062698</url>
  </required_header>
  <id_info>
    <org_study_id>2009-A00753-54</org_study_id>
    <nct_id>NCT01062698</nct_id>
  </id_info>
  <brief_title>Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy in Acute Ischemic Stroke</brief_title>
  <acronym>THRACE</acronym>
  <official_title>The Contribution of Intra-arterial Thrombectomy in Acute Ischemic Stroke in Patients Treated With Intravenous Thrombolysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <brief_summary>
    <textblock>
      THRACE is a controled, multicenter and randomized trial.

      The primary objective of this study is to determine whether a combined approach intravenous
      thrombolysis (IV) + Mechanical thrombectomy is superior to the reference treatment with IV
      thrombolysis alone, in the 3 hours of onset of symptoms in patients with occlusion of
      proximal cerebral arteries and with a neurological impairment accident (National Institutes
      of Health Stroke Scale [NIHSS] â‰¥ 10).

      The second objective is to determine the cost-effectiveness of this procedure compared to the
      standard (IV thrombolysis). The assumption is that the combined approach, by improving the
      clinical outcome and speed recovery, allows for lower overall costs to the IV thrombolysis in
      3 months and less than or at worst neutral to 1 year.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Efficacy
  </why_stopped>
  <start_date>June 2010</start_date>
  <completion_date>March 2016</completion_date>
  <primary_completion_date>December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Rankin Score (mRs )</measure>
    <time_frame>3 months after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (Euroqol EQ-5D)</measure>
    <time_frame>3 months after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barthel Score</measure>
    <time_frame>3 months after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">412</enrollment>
  <condition>Cerebral Stroke</condition>
  <condition>Cerebrovascular Accident</condition>
  <arm_group>
    <arm_group_label>IV thrombolysis + thrombectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>IV thrombolysis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alteplase (rt-PA)/Actilyse</intervention_name>
    <description>Injection of 0.9 mg/kg for 60min with an initial 10% bolus injection.</description>
    <arm_group_label>IV thrombolysis + thrombectomy</arm_group_label>
    <arm_group_label>IV thrombolysis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mechanic thrombectomy (MERCI, PENUMBRA, CATCH, SOLITAIRE)</intervention_name>
    <description>Mechanic thrombectomy</description>
    <arm_group_label>IV thrombolysis + thrombectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  10&lt;=NIHSS Score=&lt;25

          -  Symptoms onset less than 4 hours

          -  Occlusion of the intracranial carotid, the middle cerebral artery (M1) or the upper
             third of the basilar

        Exclusion Criteria:

          -  Contraindications for intravenous thrombolysis

          -  Occlusion or stenosis of the pre-occlusive cervical internal carotid artery
             ipsilateral to the lesion

          -  Any cause local prohibiting femoral catheterization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Serge Bracard, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Hospital Nancy France (HNF)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Hospital Nancy (Central HNF)</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2010</study_first_submitted>
  <study_first_submitted_qc>February 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2010</study_first_posted>
  <last_update_submitted>July 20, 2017</last_update_submitted>
  <last_update_submitted_qc>July 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Directeur de la Recherche et de l'Innovation</investigator_full_name>
    <investigator_title>Professor Serge BRACARD</investigator_title>
  </responsible_party>
  <keyword>mechanical Thrombectomy</keyword>
  <keyword>CVA (Cerebrovascular Accident)</keyword>
  <keyword>Cerebrovascular Accident, Acute</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Plasminogen Activator</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

